Skip to main content
JNCI Journal of the National Cancer Institute logoLink to JNCI Journal of the National Cancer Institute
. 2024 Jul 26;116(9):1535. doi: 10.1093/jnci/djae174

Correction to: Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome

PMCID: PMC11378303  PMID: 39058896

This is a correction to: Yurong Song, Holli Loomans-Kropp, Ryan N Baugher, Brandon Somerville, Shaneen S Baxter, Travis D Kerr, Teri M Plona, Stephanie D Mellott, Todd B Young, Heidi E Lawhorn, Lei Wei, Qiang Hu, Song Liu, Alan Hutson, Ligia Pinto, John D Potter, Shizuko Sei, Ozkan Gelincik, Steven M Lipkin, Johannes Gebert, Matthias Kloor, Robert H Shoemaker, Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome, JNCI: Journal of the National Cancer Institute, Volume 116, Issue 6, June 2024, Pages 957–965, https://doi.org/10.1093/jnci/djae060

In the originally published version of this paper, errors were present in the headings of Table 4, whereby the terms “Tumor”, “Buffy coat” and “Adjacent normal” were incorrectly placed over the columns showing values for “Variants, No.” and “Targets, No. (%)”.

This has been corrected online.


Articles from JNCI Journal of the National Cancer Institute are provided here courtesy of Oxford University Press

RESOURCES